In 50 patients with diabetic macular oedema, dexamethasone implant plus aflibercept vs aflibercept alone showed no significant difference in retinal thickness (P=0.183) or acuity at 48 weeks; oedema resolved sooner, but with more cataract and pressure rises.
RCTn = 50
Kim et al. DEXAMETHASONE IMPLANT AND AFLIBERCEPT COMBINATION THERAPY VERSUS AFLIBERCEPT MONOTHERAPY FOR DIABETIC MACULAR EDEMA: A Prospective, Comparative Trial (COED Trial)